Loss of Consciousness
7
1
1
4
Key Insights
Highlights
Success Rate
67% trial completion
Treatment Research
13 treatments under study, led by 002 Mgkg Age65
Research Leaders
10 sponsors active, led by Julien Maillard
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
28.6%
2 terminated out of 7 trials
66.7%
-19.9% vs benchmark
29%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Brain Networks and Consciousness
Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Trials
Remimazolam Bolus for General Anesthesia
Sufentanil Bispectral Index Elderly
The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial
Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness
Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope
Research Network
Common Treatments
- 002 Mgkg Age651
- Normal Saline1
- Interview1
- 027 Mgkg Age651
- Dexmedetomidine1
Active Sponsors
- Julien Maillard1
- University of California, Los Angeles1
- University of Texas Southwestern Medical Center1
- University of Geneva, Switzerland1
- Ecole Polytechnique Fédérale de Lausanne1
Top Investigators
University Hospitals of Geneva, Department of Anesthesiology
GangnamSeveracne Hospital
HUAngers
University of Texas Southwestern Medical Center
Freiburg University Medical Center
Related Conditions
- Critical Illness1
- Parkinson Disease1
- Essential Tremor1
- Anesthesia1
- Neurocardiogenic Syncope1